Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,594.00    28.00 (0.61%)
Bid:
4,592.00
Ask:
4,594.00
Spread: 2.00 (0.044%)
Market Cap: £16.74b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Directorate Change

21 Jun 2017 09:26

RNS Number : 7109I
Coca-Cola HBC AG
21 June 2017
 

FOR IMMEDIATE RELEASE

 

Coca-Cola HBC AG

Composition of the Committees of the Board of Directors of Coca‑Cola HBC AG and determination of a new member of the Board of Directors of Coca‑Cola HBC AG

 

 

Zug, Switzerland - 21 June 2017 - Coca‑Cola HBC AG ("Coca‑Cola HBC" or the "Company") announces today that its board of directors (the "Board") has appointed Ms. Charlotte J. Boyle as a member of the Remuneration Committee, with effect from 20 June 2017.

This appointment has been made pursuant to the announcement released by Coca‑Cola HBC on 15 May 2017 and the election of Ms. Charlotte J. Boyle as a non-executive member of the Board at the Company's annual general meeting held on 20 June 2017, following the retirement of Mr. Antonio D'Amato.

The Board has determined that Ms. Charlotte J. Boyle qualifies as independent under the criteria set forth in the UK Corporate Governance Code.

Aside from the information set out above, no further information is required to be disclosed pursuant to the UK Financial Conduct Authority's Listing Rule 9.6.13 and the new non-executive director does not hold any interests in the shares of Coca‑Cola HBC.

The composition of the Board Committees will be as follows:

Audit Committee

William (Bill) W. Douglas III (Chair)

John P. Sechi

Olusola (Sola) David-Borha

Nomination Committee

Reto Francioni (Chair)

Charlotte J. Boyle

Alexandra Papalexopoulou

Remuneration Committee

Alexandra Papalexopoulou (Chair)

Charlotte J. Boyle

Reto Francioni

Social Responsibility Committee

Anastasios I. Leventis (Chair)

Alexandra Papalexopoulou

José Octavio Reyes

This announcement is made pursuant to Listing Rule 9.6.11.

 

 

 

Enquiries

Coca‑Cola HBC Group

Basak Kotler

Investor Relations Director

Tel: +44 20 37 444 231 basak.kotler@cchellenic.com

Vasso Aliferi

Investor Relations Manager

Tel: +30 210 6183 341

vasso.aliferi@cchellenic.com

Maria Livaniou

Head of Shareowner Service

Tel: +30 210 6183 106

maria.livaniou@cchellenic.com

 

International media contact:

Teneo Blue Rubicon

Rob Morgan

Anushka Mathew

Tel: +44 20 7260 2700 robert.morgan@teneobluerubicon.com anushka.mathew@teneobluerubicon.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

 ao@vando.gr

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a leading bottler of The Coca-Cola Company with a sales volume of more than 2 billion unit cases. It has a broad geographic footprint with operations in 28 countries serving a population of approximately 595 million people. Coca-Cola HBC offers a diverse range of non-alcoholic ready to drink beverages in the sparkling, juice, water, sport, energy, tea and coffee categories. Coca-Cola HBC is committed to promoting sustainable development in order to create value for its business and for society. This includes providing products that meet the beverage needs of consumers, fostering an open and inclusive work environment, conducting its business in ways that protect and preserve the environment and contribute to the socio-economic development of the local communities. Coca-Cola HBC is ranked beverage industry leader in the Dow Jones Sustainability World and Europe Indices, and is also included in the FTSE4Good Index.

 

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE: CCH) and its shares are listed on the Athens Exchange (ATHEX: EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALIFFTRSILFID
Date   Source Headline
7th Oct 202110:44 amRNSCoca-Cola HBC completes Caffe Vergnano investment
1st Oct 20218:20 amRNSIssue of equity and total voting rights
28th Sep 20212:10 pmRNSPublication of a Prospectus
20th Sep 202111:40 amRNSDirector/PDMR Shareholding
17th Sep 20212:23 pmRNS2021 Performance Share Plan
3rd Sep 20214:05 pmRNSDirector/PDMR Shareholding
1st Sep 202111:25 amRNSDirector/PDMR Shareholding
1st Sep 202110:59 amRNSIssue of equity and total voting rights
27th Aug 20218:47 amRNSDirector/PDMR Shareholding
24th Aug 202110:09 amRNSDirector/PDMR Shareholding
18th Aug 202111:48 amRNSDirector/PDMR Shareholding
18th Aug 20219:34 amRNSDirector/PDMR Shareholding
18th Aug 20219:11 amRNSDirector/PDMR Shareholding
17th Aug 20219:15 amRNSDirector/PDMR Shareholding
12th Aug 20219:00 amRNSAcquires Coca-Cola Bottling Company of Egypt
12th Aug 20217:00 amRNSStrong momentum across all segments
10th Aug 202112:04 pmRNSDirector/PDMR Shareholding
2nd Aug 202110:20 amRNSIssue of equity and total voting rights
19th Jul 20212:44 pmRNSDirector/PDMR Shareholding
9th Jul 20213:47 pmRNSNotice of Results
1st Jul 202110:52 amRNSIssue of equity and total voting rights
28th Jun 20217:00 amRNSCCH takes minority stake in Caffè Vergnano
22nd Jun 20211:55 pmRNSComposition of the Committees of the BoD
22nd Jun 20211:19 pmRNSResult of AGM
18th Jun 20212:02 pmRNSDirector/PDMR Shareholding
10th Jun 202111:57 amRNSAthens Exchange trading date of ordinary shares
1st Jun 202111:01 amRNSIssue of equity and total voting rights
21st May 20217:00 amRNSNotice of AGM
18th May 20211:50 pmRNSDirector/PDMR Shareholding
12th May 20217:00 amRNSGood start in a challenging environment
4th May 202110:12 amRNSBlock listing Interim Review
4th May 202110:05 amRNSTotal voting rights
19th Apr 20214:34 pmRNSDirector/PDMR Shareholding
19th Apr 202112:05 pmRNSNotice of Results
1st Apr 20214:09 pmRNSDirector/PDMR Shareholding
23rd Mar 20213:03 pmRNSElection of Home Member State
18th Mar 20215:12 pmRNSDirector/PDMR Shareholding
18th Mar 20212:26 pmRNS2020 integrated annual report 'Adapt to Win'
18th Mar 202112:52 pmRNSDirector/PDMR Shareholding
18th Mar 202112:27 pmRNSDirector/PDMR Shareholding
18th Mar 20219:50 amRNSDirector/PDMR Shareholding
1st Mar 20218:33 amRNSIssue of Equity
18th Feb 202112:14 pmRNSDirector/PDMR Shareholding
11th Feb 20217:00 amRNSOperational agility delivers resilient performance
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.